{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:25Z","timestamp":1792802005319,"version":"4.5.0"},"reference-count":294,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00456","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T10:35:01Z","timestamp":1585650901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":338,"title":["A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Harald","family":"Hampel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Caraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Claudio","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nistic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Baldacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia A.","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Verdooner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Akman-Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Emanuele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Luc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Watling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"2017 Alzheimer's disease facts and figures","volume":"13","author":"Association","year":"2017","journal-title":"Alzheimer's Dement."},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the national institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease : recommendations from the national institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Mckhann","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"B8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the national institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"B9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1567205014666170829100100","article-title":"Modulation of inflammation as a way of delaying Alzheimer's Disease progression: the diet's role","volume":"15","author":"Businaro","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0197-4580(96)00115-7","article-title":"Inflammation and Alzheimer's disease pathogenesis","volume":"17","author":"Rogers","year":"1996","journal-title":"Neurobiol Aging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0165-6147(94)90057-4","article-title":"Inflammatory mechanisms in Alzheimer's disease","volume":"15","author":"Eikelenboom","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3233\/JAD-180970","article-title":"Identification and preliminary validation of a plasma profile associated with cognitive decline in dementia and at-risk individuals: a retrospective cohort analysis","volume":"67","author":"Iulita","year":"2019","journal-title":"J Alzheimer's Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.tips.2017.07.005","article-title":"Early and late CNS Inflammation in Alzheimer's disease: two extremes of a continuum?","volume":"38","author":"Cuello","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jalz.2018.01.008","article-title":"Principles for central nervous system inflammation research: a call for a consortium approach","volume":"14","author":"Rogers","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"B21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","article-title":"Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview","volume":"50","author":"Brosseron","year":"2014","journal-title":"Mol Neurobiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer's disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimer's Dement"},{"key":"B23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer's disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J Neuroinflammation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"aww349","DOI":"10.1093\/brain\/aww349","article-title":"An early and late peak in microglial activation in Alzheimer's disease trajectory","volume":"140","author":"Fan","year":"2017","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.3233\/JAD-179929","article-title":"Role of neuroinflammation in the trajectory of Alzheimer's disease and in vivo quantification using PET","volume":"64","author":"Edison","year":"2018","journal-title":"J Alzheimer's Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/brain\/awx120","article-title":"Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease","volume":"140","author":"Parbo","year":"2017","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2019.00063","article-title":"Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration","volume":"13","author":"Henstridge","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.22389","article-title":"The quad-partite synapse: microglia-synapse interactions in the developing and mature CNS","volume":"61","author":"Schafer","year":"2013","journal-title":"Glia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e12937","DOI":"10.1111\/acel.12937","article-title":"Astrocyte senescence: evidence and significance","volume":"18","author":"Cohen","year":"2019","journal-title":"Aging Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2018.10.007","article-title":"Phenotypic and functional differences between senescent and aged murine microglia","volume":"74","author":"Stojiljkovic","year":"2019","journal-title":"Neurobiol Aging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","article-title":"The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications","volume":"18","author":"Arranz","year":"2019","journal-title":"Lancet Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/glia.23270","article-title":"Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease","volume":"66","author":"Gomez-Arboledas","year":"2018","journal-title":"Glia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.pharmthera.2013.04.013","article-title":"Microglia during development and aging","volume":"139","author":"Harry","year":"2013","journal-title":"Pharmacol Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2019.03.096","article-title":"Regional molecular mapping of primate synapses during normal healthy aging","volume":"27","author":"Graham","year":"2019","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tins.2019.03.003","article-title":"A unifying hypothesis for Alzheimer's disease: from Plaques to neurodegeneration","volume":"42","author":"Edwards","year":"2019","journal-title":"Trends Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","article-title":"Microglia-mediated synapse loss in Alzheimer's disease","volume":"38","author":"Rajendran","year":"2018","journal-title":"J Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2012.03.004","article-title":"Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease","volume":"34","author":"Arnold","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.brainresrev.2006.11.002","article-title":"The origin and cell lineage of microglia\u2014New concepts","volume":"53","author":"Chan","year":"2007","journal-title":"Brain Res Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer's disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-014-0142-6","article-title":"Microglial pathology","volume":"2","author":"Streit","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"JLB","DOI":"10.1002\/JLB.MR0818-319R","article-title":"Microglia in Alzheimer's disease: a target for immunotherapy","volume":"106","author":"Wang","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e101997","DOI":"10.15252\/embj.2019101997","article-title":"Microglial subtypes: diversity within the microglial community","volume":"38","author":"Stratoulias","year":"2019","journal-title":"EMBO J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2018.01.059","article-title":"The evolving dialogue of microglia and neurons in Alzheimer's disease: microglia as necessary transducers of pathology","volume":"405","author":"Simon","year":"2019","journal-title":"Neuroscience."},{"key":"B50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fnins.2019.00291","article-title":"Icariin attenuates M1 activation of microglia and A\u03b2 plaque accumulation in the hippocampus and prefrontal cortex by up-regulating PPAR\u03b3 in restraint\/isolation-stressed APP\/PS1 Mice","volume":"13","author":"Wang","year":"2019","journal-title":"Front Neurosci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-170819","article-title":"Alzheimer's disease, oligomers, and inflammation","volume":"62","author":"Forloni","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell."},{"key":"B53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2009.10.006","article-title":"Inflammation, microglia, and Alzheimer's disease","volume":"37","author":"Cameron","year":"2010","journal-title":"Neurobiol Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0076-6879(99)09048-5","article-title":"Inflammatory responses to amyloid fibrils","volume":"309","author":"Yates","year":"1999","journal-title":"Methods Enzymol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1523\/JNEUROSCI.23-07-02665.2003","article-title":"A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation","volume":"23","author":"Bamberger","year":"2003","journal-title":"J Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/brain\/awh531","article-title":"LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide","volume":"128","author":"Liu","year":"2005","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","article-title":"Microglial cells internalize aggregates of the Alzheimer's disease amyloid \u03b2-protein via a scavenger receptor","volume":"17","author":"Paresce","year":"1996","journal-title":"Neuron"},{"key":"B58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","article-title":"Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance","volume":"28","author":"Bolmont","year":"2008","journal-title":"J Neurosci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective -amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J Neurosci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/cdd.2013.180","article-title":"Microglia convert aggregated amyloid-\u03b2 into neurotoxic forms through the shedding of microvesicles","volume":"21","author":"Joshi","year":"2014","journal-title":"Cell Death Differ"},{"key":"B65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/156720511795255982","article-title":"Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?","volume":"8","author":"Ferretti","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.3233\/JAD-2012-129039","article-title":"Synaptotoxic amyloid-\u03b2 oligomers: a molecular basis for the cause, diagnosis, and treatment of alzheimer's disease?","volume":"33","author":"Klein","year":"2012","journal-title":"J Alzheimer's Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer's amyloid- oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J Neurosci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/cells8010064","article-title":"Carnosine prevents A\u03b2-induced oxidative stress and inflammation in microglial cells: a key role of TGF-\u03b21","volume":"8","author":"Caruso","year":"2019","journal-title":"Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fphar.2019.00693","article-title":"Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by A\u03b21-42 oligomers in mice: a key role of transforming growth factor-\u03b21","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","article-title":"Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease","volume":"35","author":"Hanzel","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2018.08.007","article-title":"Dephosphorylated rather than hyperphosphorylated tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway","volume":"310","author":"Perea","year":"2018","journal-title":"Exp Neurol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s11481-013-9480-6","article-title":"Immune players in the CNS: the astrocyte","volume":"8","author":"Jensen","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S1740925X10000207","article-title":"Is astrocyte calcium signaling relevant for synaptic plasticity?","volume":"6","author":"Ben Achour","year":"2010","journal-title":"Neuron Glia Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2010-101089","article-title":"Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity","volume":"22","author":"Vincent","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","article-title":"The tripartite synapse: roles for gliotransmission in health and disease","volume":"13","author":"Halassa","year":"2007","journal-title":"Trends Mol Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1523\/JNEUROSCI.1419-07.2007","article-title":"Synaptic islands defined by the territory of a single astrocyte","volume":"27","author":"Halassa","year":"2007","journal-title":"J Neurosci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tins.2006.08.004","article-title":"Astrocytic complexity distinguishes the human brain","volume":"29","author":"Oberheim","year":"2006","journal-title":"Trends Neurosci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","article-title":"Molecular dissection of reactive astrogliosis and glial scar formation","volume":"32","author":"Sofroniew","year":"2009","journal-title":"Trends Neurosci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2012.10.007","article-title":"Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony","volume":"239","author":"Medeiros","year":"2013","journal-title":"Exp Neurol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/glia.20967","article-title":"Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease","volume":"58","author":"Olabarria","year":"2010","journal-title":"Glia"},{"key":"B84","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neurobiolaging.2014.09.027","article-title":"Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes","volume":"36","author":"Sekar","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B85","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s004010050790","article-title":"Diffuse plaques associated with astroglial amyloid \u03b2 protein, possibly showing a disappearing stage of senile plaques","volume":"95","author":"Yamaguchi","year":"1998","journal-title":"Acta Neuropathol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-\u03b2 in vitro and in situ","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X","article-title":"Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism","volume":"16","author":"Chao","year":"1996","journal-title":"Glia"},{"key":"B88","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40142-018-0155-8","article-title":"A brief synopsis on the genetics of Alzheimer's disease","volume":"6","author":"Kamboh","year":"2018","journal-title":"Curr Genet Med Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's sisease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"B91","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat Neurosci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1007427","DOI":"10.1371\/journal.pgen.1007427","article-title":"Paired immunoglobulin-like type 2 receptor alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease","volume":"14","author":"Rathore","year":"2018","journal-title":"PLoS Genet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12974-018-1148-y","article-title":"TREM2 regulates innate immunity in Alzheimer's disease","volume":"15","author":"Li","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B94","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fnagi.2018.00395","article-title":"TREM2 in Alzheimer's disease: microglial survival and energy metabolism","volume":"10","author":"Zheng","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"jem","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival","volume":"214","author":"Zhong","year":"2017","journal-title":"J Exp Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","article-title":"TREM2 and the neuroimmunology of Alzheimer's disease","volume":"88","author":"Hickman","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ajhg.2017.09.009","article-title":"Inferring relevant cell types for complex traits by using single-cell gene expression","volume":"101","author":"Calderon","year":"2017","journal-title":"Am J Hum Genet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's Disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer's disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"key":"B100","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-017-0200-1","article-title":"Absence of CX3CR1 impairs the internalization of tau by microglia","volume":"12","author":"Bol\u00f3s","year":"2017","journal-title":"Mol Neurodegener"},{"key":"B101","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbi.2017.10.002","article-title":"Absence of microglial CX3CR1 impairs the synaptic integration of adult-born hippocampal granule neurons","volume":"68","author":"Bol\u00f3s","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fnins.2018.00609","article-title":"Decreased CX3CL1 levels in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"12","author":"Perea","year":"2018","journal-title":"Front Neurosci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajhg.2019.03.010","article-title":"Homozygous mutations in CSF1R cause a pediatric-onset leukoencephalopathy and can result in congenital absence of microglia","volume":"104","author":"Oosterhof","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ajhg.2019.03.004","article-title":"Bi-allelic CSF1R mutations cause skeletal dysplasia of dysosteosclerosis-pyle disease spectrum and degenerative encephalopathy with brain malformation","volume":"104","author":"Guo","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2013.10.007","article-title":"Microglial derived tumor necrosis factor-\u03b1 drives Alzheimer's disease-related neuronal cell cycle events","volume":"62","author":"Bhaskar","year":"2014","journal-title":"Neurobiol Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1172\/JCI39716","article-title":"NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease","volume":"119","author":"Varvel","year":"2009","journal-title":"J Clin Invest"},{"key":"B107","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.clinph.2009.02.005","article-title":"Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease","volume":"120","author":"Babiloni","year":"2009","journal-title":"Clin Neurophysiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-2004-6206","article-title":"Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets","volume":"6","author":"Mhatre","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ynstr.2018.05.003","article-title":"Chronic stress as a risk factor for Alzheimer's disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress","volume":"9","author":"Bisht","year":"2018","journal-title":"Neurobiol Stress"},{"key":"B110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pneurobio.2018.12.004","article-title":"Pivotal role of carnosine in the modulation of brain cells activity: multimodal mechanism of action and therapeutic potential in neurodegenerative disorders","volume":"175","author":"Caruso","year":"2019","journal-title":"Prog Neurobiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/JIR.S4397","article-title":"Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease","volume":"1","author":"McAlpine","year":"2008","journal-title":"J Inflamm Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/brain\/awu318","article-title":"Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease","volume":"138","author":"Cantarella","year":"2015","journal-title":"Brain"},{"key":"B113","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1567205013666160930110551","article-title":"Targeting tumor necrosis factor alpha for Alzheimer's disease","volume":"14","author":"Decourt","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/gps.4871","article-title":"TNF alpha inhibitors in Alzheimer's disease: a systematic review","volume":"33","author":"Ekert","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"B115","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1871527315666160321104916","article-title":"A link between nerve growth factor metabolic deregulation and amyloid-\u03b2-driven inflammation in down syndrome","volume":"15","author":"Iulita","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B116","doi-asserted-by":"publisher","first-page":"49523","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-\u03b1, interleukin-1\u03b2, and interferon-\u03b3 stimulate \u03b3-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway","volume":"279","author":"Liao","year":"2004","journal-title":"J Biol Chem"},{"key":"B117","doi-asserted-by":"publisher","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","article-title":"Microglial phagocytosis induced by fibrillar -amyloid and IgGs are differentially regulated by proinflammatory cytokines","volume":"25","author":"Koenigsknecht-Talboo","year":"2005","journal-title":"J Neurosci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1124\/pr.112.005850","article-title":"Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales","volume":"64","author":"Clark","year":"2012","journal-title":"Pharmacol Rev"},{"key":"B119","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's \u03b2-Amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab"},{"key":"B120","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1111\/j.1460-9568.2006.05109.x","article-title":"Altered subcellular location of phosphorylated smads in Alzheimer's disease","volume":"24","author":"Ueberham","year":"2006","journal-title":"Eur J Neurosci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-\u03b2 signaling promotes neurodegeneration and Alzheimer's pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J Clin Invest"},{"key":"B123","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00441-011-1230-6","article-title":"Dysfunction of TGF-\u03b21 signaling in Alzheimer's disease: perspectives for neuroprotection","volume":"347","author":"Caraci","year":"2012","journal-title":"Cell Tissue Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/1673-5374.125328","article-title":"Dab2 attenuates brain injury in APP\/PS1 mice via targeting transforming growth factor-beta\/SMAD signaling","volume":"9","author":"Liu","year":"2014","journal-title":"Neural Regen Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e0116549","DOI":"10.1371\/journal.pone.0116549","article-title":"Protection of TGF-\u03b21 against Neuroinflammation and Neurodegeneration in A\u03b21\u201342-Induced Alzheimer's Disease Model Rats","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/jnr.23082","article-title":"Transforming growth factor-\u03b2 stimulates \u03b2 amyloid uptake by microglia through Smad3-dependent mechanisms","volume":"90","author":"Tichauer","year":"2012","journal-title":"J Neurosci Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1038\/srep11252","article-title":"A key role for TGF-\u03b21 in hippocampal synaptic plasticity and memory","volume":"5","author":"Caraci","year":"2015","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/alzrt37","article-title":"The involvement of cell cycle events in the pathogenesis of Alzheimer's disease","volume":"2","author":"Herrup","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.neurobiolaging.2007.02.027","article-title":"Interleukin-1\u03b2 impairs brain derived neurotrophic factor-induced signal transduction","volume":"29","author":"Tong","year":"2008","journal-title":"Neurobiol Aging"},{"key":"B130","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nbd.2017.08.019","article-title":"Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease","volume":"108","author":"Iulita","year":"2017","journal-title":"Neurobiol Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s12035-014-8958-4","article-title":"Brain-Derived neurotrophic factor in Alzheimer's disease: risk, mechanisms, and therapy","volume":"52","author":"Song","year":"2015","journal-title":"Mol Neurobiol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/brain\/awt372","article-title":"Nerve growth factor metabolic dysfunction in down's syndrome brains","volume":"137","author":"Iulita","year":"2014","journal-title":"Brain"},{"key":"B133","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnins.2019.00062","article-title":"The brain NGF metabolic pathway in health and in Alzheimer's pathology","volume":"13","author":"Cuello","year":"2019","journal-title":"Front Neurosci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","article-title":"Amyloid \u03b2-Induced nerve growth factor dysmetabolism in Alzheimer disease","volume":"68","author":"Bruno","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/NEN.0b013e3181c22569","article-title":"Increased matrix metalloproteinase 9 activity in mild cognitive impairment","volume":"68","author":"Bruno","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.drudis.2014.06.029","article-title":"Targeting TNF: a therapeutic strategy for Alzheimer's disease","volume":"19","author":"Cheng","year":"2014","journal-title":"Drug Discov Today"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/nature04671","article-title":"Synaptic scaling mediated by glial TNF-\u03b1","volume":"440","author":"Stellwagen","year":"2006","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1111\/j.1460-9568.2005.04457.x","article-title":"\u03b2-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor","volume":"22","author":"Wang","year":"2005","journal-title":"Eur J Neurosci"},{"key":"B139","doi-asserted-by":"publisher","first-page":"117957351772251","DOI":"10.1177\/1179573517722512","article-title":"Inhibition of inflammation mediated through the tumor necrosis factor \u03b1 biochemical pathway can lead to favorable outcomes in Alzheimer disease","volume":"9","author":"Shamim","year":"2017","journal-title":"J Cent Nerv Syst Dis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer's disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol Aging"},{"key":"B141","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/hipo.20542","article-title":"The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo","volume":"19","author":"Schmid","year":"2009","journal-title":"Hippocampus"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/nm.2965","article-title":"Inhibition of IL-12\/IL-23 signaling reduces Alzheimer's disease\u2013like pathology and cognitive decline","volume":"18","author":"vom Berg","year":"2012","journal-title":"Nat Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000107700","article-title":"Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment","volume":"4","author":"Guerreiro","year":"2007","journal-title":"Neurodegener Dis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1056\/NEJMcibr1214546","article-title":"Neuroinflammatory cytokine signaling and Alzheimer's disease","volume":"368","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/gt.2011.126","article-title":"AAV serotype 2\/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice","volume":"19","author":"Kiyota","year":"2012","journal-title":"Gene Ther"},{"key":"B146","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 Alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"B147","doi-asserted-by":"publisher","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","article-title":"Synaptic pruning by microglia is necessary for normal brain development","volume":"333","author":"Paolicelli","year":"2011","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"B150","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"B152","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiol Aging"},{"key":"B153","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/187152710791011991","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease","volume":"9","author":"Cole","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B154","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/brain\/awn008","article-title":"Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity","volume":"131","author":"Kotilinek","year":"2008","journal-title":"Brain"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/brain\/aww117","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice","volume":"139","author":"Woodling","year":"2016","journal-title":"Brain"},{"key":"B156","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nrneurol.2016.79","article-title":"NSAIDs protect neurons and preserve memory in a mouse model of AD","volume":"12","author":"Malkki","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fphar.2019.00310","article-title":"Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: cornerstones for Alzheimer's precision medicine and pharmacology","volume":"10","author":"Hampel","year":"2019","journal-title":"Front Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/brain\/awz142","article-title":"Persistent neuropathological effects 14 years following amyloid-\u03b2 immunization in Alzheimer's disease","volume":"142","author":"Nicoll","year":"2019","journal-title":"Brain"},{"key":"B159","doi-asserted-by":"publisher","first-page":"101662","DOI":"10.1016\/j.pneurobio.2019.101662","article-title":"Time for the systems-level integration of aging: resilience enhancing strategies to prevent Alzheimer's disease","volume":"181","author":"Hampel","year":"2019","journal-title":"Prog Neurobiol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B161","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B162","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/psyg.12403","article-title":"Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"19","author":"Su","year":"2019","journal-title":"Psychogeriatrics"},{"key":"B163","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B164","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-150042","article-title":"Inflammatory markers in mild cognitive impairment: a meta-Analysis","volume":"47","author":"Saleem","year":"2015","journal-title":"J Alzheimer's Dis"},{"key":"B165","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","article-title":"Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis","volume":"76","author":"Dhiman","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B167","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14789450.2017.1304217","article-title":"Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases","volume":"14","author":"Baldacci","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"B168","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/14789450.2019.1628643","article-title":"The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development","volume":"16","author":"Baldacci","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"B169","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B170","doi-asserted-by":"publisher","first-page":"177","DOI":"10.31887\/DCNS.2019.21.2\/hhampel","article-title":"Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease?","volume":"21","author":"Hampel","year":"2019","journal-title":"Dialogues Clin Neurosci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yfrne.2018.06.001","article-title":"Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification","volume":"50","author":"Hampel","year":"2018","journal-title":"Front Neuroendocrinol."},{"key":"B172","first-page":"139","article-title":"Blood-based biomarker screening with agnostic biological definitions for an accurate diagnosis within the dimensional spectrum of neurodegenerative diseases","volume-title":"Methods in Molecular Biology","author":"Baldacci","year":"2016"},{"key":"B173","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0361-9230(03)00088-1","article-title":"Cerebral pattern of pro- and anti-inflammatory cytokines in dementias","volume":"61","author":"Tarkowski","year":"2003","journal-title":"Brain Res Bull"},{"key":"B174","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.biopsych.2008.07.019","article-title":"All-or-Nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's \u03b2-Amyloid Peptide","volume":"64","author":"Teixeira","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B175","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12883-016-0707-z","article-title":"Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1\u03b2","volume":"16","author":"Hesse","year":"2016","journal-title":"BMC Neurol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e64971","DOI":"10.1371\/journal.pone.0064971","article-title":"Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer's Disease","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS ONE"},{"key":"B177","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000071001","article-title":"Inflammatory Markers in Matched Plasma and Cerebrospinal Fluid from Patients with Alzheimer's Disease","volume":"16","author":"Sun","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B178","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","article-title":"Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease","volume":"117","author":"Bermejo","year":"2008","journal-title":"Immunol Lett"},{"key":"B179","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, toward a consensus: report of the international working group on mild cognitive impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"B182","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/clc.4960241103","article-title":"Interleukin-6 and acute coronary syndrome","volume":"24","author":"Ikeda","year":"2001","journal-title":"Clin Cardiol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","article-title":"Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease","volume":"36","author":"Villegas-Llerena","year":"2016","journal-title":"Curr Opin Neurobiol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e0139089","DOI":"10.1371\/journal.pone.0139089","article-title":"Dynamic FDG-PET imaging to differentiate malignancies from inflammation in subcutaneous and in situ mouse model for Non-Small Cell Lung Carcinoma (NSCLC)","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS ONE"},{"key":"B185","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","article-title":"Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain","volume":"35","author":"Cosenza-Nashat","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","article-title":"Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study","volume":"32","author":"Edison","year":"2008","journal-title":"Neurobiol Dis"},{"key":"B187","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2012.04.021","article-title":"Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study","volume":"34","author":"Schuitemaker","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311336","article-title":"Imaging of neuroinflammation in dementia: a review","volume":"87","author":"Stefaniak","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B189","doi-asserted-by":"publisher","first-page":"e1989","DOI":"10.1212\/WNL.0000000000005610","article-title":"[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy","volume":"90","author":"Passamonti","year":"2018","journal-title":"Neurology"},{"key":"B190","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","article-title":"Influence of microglial activation on neuronal function in Alzheimer's and parkinson's disease dementia","volume":"11","author":"Fan","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"B191","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","article-title":"Cytokine expression and microglial activation in progressive supranuclear palsy","volume":"17","author":"Fern\u00e1ndez-Botr\u00e1n","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"B192","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2967\/jnumed.110.079459","article-title":"Mixed-affinity binding in humans with 18-kDa translocator protein ligands","volume":"52","author":"Owen","year":"2011","journal-title":"J Nucl Med"},{"key":"B193","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","article-title":"Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging","volume":"32","author":"Lavisse","year":"2012","journal-title":"J Neurosci"},{"key":"B194","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2967\/jnumed.114.149955","article-title":"In Vivo pet imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis","volume":"56","author":"Airas","year":"2015","journal-title":"J Nucl Med"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","article-title":"Quantitation of translocator protein binding in human brain with the novel radioligand [ 18 F]-FEPPA and positron emission tomography","volume":"31","author":"Rusjan","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"B196","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00259-015-3228-x","article-title":"Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"43","author":"Morris","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B197","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","article-title":"Tau PET imaging: present and future directions","volume":"12","author":"Saint-Aubert","year":"2017","journal-title":"Mol Neurodegener"},{"key":"B198","doi-asserted-by":"publisher","first-page":"aww340","DOI":"10.1093\/brain\/aww340","article-title":"18 F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy","volume":"140","author":"Passamonti","year":"2017","journal-title":"Brain."},{"key":"B199","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2967\/jnumed.108.057356","article-title":"PET of glial metabolism using 2-18F-Fluoroacetate","volume":"50","author":"Marik","year":"2009","journal-title":"J Nucl Med"},{"key":"B200","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/ijms18040802","article-title":"Molecular targets for PET imaging of activated microglia: the current situation and future expectations","volume":"18","author":"Tronel","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B201","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2967\/jnumed.115.166116","article-title":"Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in alzheimers disease model mice","volume":"57","author":"Shukuri","year":"2016","journal-title":"J Nucl Med"},{"key":"B202","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB 2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"B204","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ejmech.2015.01.028","article-title":"Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor","volume":"92","author":"Slavik","year":"2015","journal-title":"Eur J Med Chem"},{"key":"B205","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2967\/jnumed.116.181354","article-title":"Characterization of 11 C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation","volume":"58","author":"Territo","year":"2017","journal-title":"J Nucl Med"},{"key":"B206","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnagi.2018.00083","article-title":"NSAID exposure and risk of Alzheimer's disease: an updated meta-analysis from cohort studies","volume":"10","author":"Zhang","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B207","article-title":"Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer's disease","volume-title":"Sixth International Stockholm\/Springfield Symposium on Advances in Alzheimer Therapy","author":"Sainati","year":"2000"},{"key":"B208","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000096588","article-title":"Long-term efficacy and safety of celecoxib in Alzheimer's Disease","volume":"23","author":"Soininen","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B209","article-title":"Alzheimer disease: dapsone phase 2 trial results reported","author":"Bain","year":""},{"key":"B210","unstructured":"A double-blind, placebo-controlled trial of diclofenac\/misoprostol in Alzheimer's disease197201\n            ScharfS\n            ManderA\n            UgoniA\n            VajdaF\n            ChristophidisNP\n          10.1212\/WNL.53.1.19710408559Neurology531999"},{"key":"B211","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(01)05623-9","article-title":"Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study","volume":"358","author":"Van Gool","year":"2001","journal-title":"Lancet"},{"key":"B212","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF03325217","article-title":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease","volume":"21","author":"Pasqualetti","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology"},{"key":"B214","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1371\/journal.pone.0001475","article-title":"No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial","volume":"3","author":"de Jong","year":"2008","journal-title":"PLoS ONE"},{"key":"B215","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1212\/WNL.58.7.1050","article-title":"Randomized pilot study of nimesulide treatment in Alzheimer's disease","volume":"58","author":"Aisen","year":"2002","journal-title":"Neurology"},{"key":"B217","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1212\/WNL.54.3.588","article-title":"A randomized controlled trial of prednisone in Alzheimer's disease","volume":"54","author":"Aisen","year":"2000","journal-title":"Neurology"},{"key":"B218","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"B219","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(08)70090-5","article-title":"Tarenflurbil Phase II Study investigators. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial","volume":"7","author":"Wilcock","year":"2008","journal-title":"Lancet Neurol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild alzheimer disease a randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2009.05.220","article-title":"Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: results from an 18-month international multi-center Phase 3 trial","volume":"5","author":"Wilcock","year":"2009","journal-title":"Alzheimers Dement"},{"key":"B222","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/JGP.0b013e31818cd3a4","article-title":"Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study","volume":"16","author":"Small","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B224","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/WAD.0b013e3181611024","article-title":"A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study","volume":"22","author":"G\u00f3mez-Isla","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"key":"B226","doi-asserted-by":"publisher","first-page":"e2070","DOI":"10.1212\/WNL.0000000000007232","article-title":"INTREPAD: a randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease","volume":"92","author":"Meyer","year":"2019","journal-title":"Neurology"},{"key":"B227","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jalz.2012.11.012","article-title":"Results of a follow-up study to the randomized Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)","volume":"9","year":"2013","journal-title":"Alzheimers Dement"},{"key":"B228","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","article-title":"Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)","volume":"65","author":"Martin","year":"2008","journal-title":"Arch Neurol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000078501","article-title":"Nonsteroidal Anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review","volume":"23","author":"Szekely","year":"2004","journal-title":"Neuroepidemiology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's Disease","volume":"345","author":"in","year":"2001","journal-title":"N Engl J Med"},{"key":"B231","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"B232","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/aje\/kwi029","article-title":"Meta-Analysis of nonsteroidal antiinflammatory drug use and risk of dementia","volume":"161","author":"de Craen","year":"2005","journal-title":"Am J Epidemiol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/WAD.0000000000000098","article-title":"NSAID use and incident cognitive impairment in a population-based cohort","volume":"30","author":"Wichmann","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"B234","unstructured":"RogersMB\n          Antibodies against microglial receptors TREM2 and CD33 head to trials | ALZFORUM.2019"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"Steed","year":"2003","journal-title":"Science"},{"key":"B236","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","article-title":"Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection","volume":"179","author":"Zalevsky","year":"2007","journal-title":"J Immunol"},{"key":"B237","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bbi.2019.08.195","article-title":"TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex","volume":"82","author":"Yli-Karjanmaa","year":"2019","journal-title":"Brain Behav Immun"},{"key":"B238","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","article-title":"Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice","volume":"102","author":"MacPherson","year":"2017","journal-title":"Neurobiol Dis"},{"key":"B239","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2016.07.009","article-title":"Inhibiting tumor necrosis factor-\u03b1 before amyloidosis prevents synaptic deficits in an Alzheimer's disease model","volume":"47","author":"Cavanagh","year":"2016","journal-title":"Neurobiol Aging"},{"key":"B240","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol Dis"},{"key":"B241","doi-asserted-by":"publisher","first-page":"e38170","DOI":"10.1371\/journal.pone.0038170","article-title":"Inhibition of soluble tumor necrosis factor ameliorates synaptic alterations and Ca2+ dysregulation in aged rats","volume":"7","author":"Sama","year":"2012","journal-title":"PLoS ONE"},{"key":"B242","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1128\/MCB.00544-13","article-title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia","volume":"33","author":"Li","year":"2013","journal-title":"Mol Cell Biol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1212\/NXI.0000000000000100","article-title":"Randomized phase 2 trial of NP001-a novel immune regulator: Safetyearly efficacy in ALS","volume":"2","author":"Miller","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B244","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","article-title":"A serum protein\u2013based algorithm for the detection of Alzheimer Disease","volume":"67","author":"O'Bryant","year":"2010","journal-title":"Arch Neurol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"e28092","DOI":"10.1371\/journal.pone.0028092","article-title":"A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI","volume":"6","author":"O'Bryant","year":"2011","journal-title":"PLoS ONE"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-141041","article-title":"Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues","volume":"42","author":"O'Bryant","year":"2014","journal-title":"J Alzheimer's Dis"},{"key":"B248","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-180619","article-title":"A precision medicine model for targeted NSAID therapy in Alzheimer's Disease","volume":"66","author":"O'Bryant","year":"2018","journal-title":"J Alzheimer's Dis"},{"key":"B249","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"B250","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"B253","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1523\/JNEUROSCI.3537-10.2010","article-title":"Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils","volume":"30","author":"O'Nuallain","year":"2010","journal-title":"J Neurosci"},{"key":"B254","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.brainres.2016.08.016","article-title":"Amyloid-\u03b242 protofibrils are internalized by microglia more extensively than monomers","volume":"1648","author":"Gouwens","year":"2016","journal-title":"Brain Res"},{"key":"B255","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1021\/cn2001238","article-title":"Isolated Amyloid-\u03b2(1\u201342) Protofibrils, but not isolated fibrils, are robust stimulators of microglia","volume":"3","author":"Paranjape","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"B256","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12974-018-1134-4","article-title":"The A\u03b2 protofibril selective antibody mAb158 prevents accumulation of A\u03b2 in astrocytes and rescues neurons from A\u03b2-induced cell death","volume":"15","author":"S\u00f6llvander","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B257","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1471-4159.2007.04759.x","article-title":"Sensitive ELISA detection of amyloid-beta protofibrils in biological samples","volume":"103","author":"Englund","year":"2007","journal-title":"J Neurochem"},{"key":"B258","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/glia.21004","article-title":"Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins","volume":"58","author":"Nielsen","year":"2010","journal-title":"Glia"},{"key":"B259","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-016-0181-2","article-title":"Safety and tolerability of BAN2401\u2013a clinical study in Alzheimer's disease with a protofibril selective A\u03b2 antibody","volume":"8","author":"Logovinsky","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"B260","unstructured":"FaganT\n            StrobelG\n          BAN2401 Removes Brain Amyloid, Possibly Slows Cognitive Decline2016"},{"key":"B261","unstructured":"Presented at the 11thClinical Trials on Alzheimer's Disease (CTAD) Conference October 24\u2013272018"},{"key":"B262","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1113\/jphysiol.2010.201327","article-title":"Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle","volume":"589","author":"Powers","year":"2011","journal-title":"J Physiol"},{"key":"B263","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/antiox7010017","article-title":"Cytokine response to exercise and its modulation","volume":"7","author":"Suzuki","year":"2018","journal-title":"Antioxidants"},{"key":"B264","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/153.3.242","article-title":"Association between physical activity and markers of inflammation in a healthy elderly population","volume":"153","author":"Geffken","year":"2001","journal-title":"Am J Epidemiol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1161\/hc1502.107117","article-title":"physical activity and hemostatic and inflammatory variables in elderly men","volume":"105","author":"Wannamethee","year":"2002","journal-title":"Circulation"},{"key":"B266","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1123\/jpah.2016-0735","article-title":"Effect of exercise on inflammatory profile of older persons: systematic review and meta-analyses","volume":"15","author":"Monteiro-Junior","year":"2018","journal-title":"J Phys Act Heal"},{"key":"B267","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jalz.2016.05.004","article-title":"Effect of aerobic exercise on physical performance in patients with Alzheimer's disease","volume":"12","author":"Sobol","year":"2016","journal-title":"Alzheimer's Dement"},{"key":"B268","doi-asserted-by":"publisher","first-page":"P323","DOI":"10.1016\/j.jalz.2015.07.465","article-title":"Regular multimodal aerobic exercise reduces pro-inflammatory cytokines and improves BDNF peripheral levels and executive functions in elderly MCI individuals with different BDNF Val66Met genotypes","volume":"11","author":"Nascimento","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"B269","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3233\/JAD-160869","article-title":"Treadmill exercise exerts neuroprotection and regulates microglial polarization and oxidative stress in a streptozotocin-induced rat model of sporadic Alzheimer's disease","volume":"56","author":"Lu","year":"2017","journal-title":"J Alzheimer's Dis"},{"key":"B270","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fnmol.2017.00144","article-title":"Voluntary exercise promotes glymphatic clearance of amyloid beta and reduces the activation of astrocytes and microglia in aged mice","volume":"10","author":"He","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B271","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fncel.2017.00404","article-title":"Physical exercise improves cognitive function together with microglia phenotype modulation and remyelination in chronic cerebral hypoperfusion","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B272","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1186\/1742-2094-10-114","article-title":"Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice","volume":"10","author":"Kohman","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B273","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fneur.2018.00698","article-title":"Endocrine crosstalk between skeletal muscle and the brain","volume":"9","author":"Delezie","year":"2018","journal-title":"Front Neurol"},{"key":"B274","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1152\/physiol.00019.2013","article-title":"Exercise is the real polypill","volume":"28","author":"Fiuza-Luces","year":"2013","journal-title":"Physiology"},{"key":"B275","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","article-title":"The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease","volume":"11","author":"Gleeson","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B276","first-page":"130","article-title":"Exercise, inflammation and aging","volume":"3","author":"Woods","year":"2012","journal-title":"Aging Dis"},{"key":"B277","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nri2566","article-title":"Reflex control of immunity","volume":"9","author":"Tracey","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"B279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-181121","article-title":"The Alzheimer precision medicine initiative (APMI)","volume":"68","author":"Hampel","year":"2019","journal-title":"J Alzheimer's Dis"},{"key":"B280","doi-asserted-by":"publisher","first-page":"1254665","DOI":"10.1126\/science.1254665","article-title":"Intersection of population variation and autoimmunity genetics in human T cell activation","volume":"345","author":"Ye","year":"2014","journal-title":"Science"},{"key":"B281","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.immuni.2014.03.002","article-title":"Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli","volume":"40","author":"Duffy","year":"2014","journal-title":"Immunity"},{"key":"B282","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nri3820","article-title":"Immune biomarkers: the promises and pitfalls of personalized medicine","volume":"15","author":"Willis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B283","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork","year":"2015","journal-title":"Nature"},{"key":"B284","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41540-017-0045-9","article-title":"A roadmap toward personalized immunology","volume":"4","author":"Delhalle","year":"2018","journal-title":"NPJ Syst Biol Appl"},{"key":"B285","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.3233\/JAD-179932","article-title":"Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology","volume":"64","author":"Hampel","year":"2018","journal-title":"J Alzheimer's Dis"},{"key":"B286","first-page":"31","article-title":"Systems biology methods for alzheimer's disease research toward molecular signatures, subtypes, and stages and precision medicine: application in cohort studies and trials","volume-title":"Methods in Molecular Biology","author":"Castrillo","year":"2016"},{"key":"B287","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/ijms17091555","article-title":"Omics-Based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations","volume":"17","author":"Tebani","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B288","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/10408363.2017.1384446","article-title":"Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction","volume":"54","author":"Dimitrakopoulos","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B289","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cca.2019.08.010","article-title":"Proteogenomics: from next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine","volume":"498","author":"Ang","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B290","first-page":"49","article-title":"Application of systems theory in longitudinal studies on the origin and progression of Alzheimer's Disease","volume-title":"Methods in Molecular Biology","author":"Lista","year":"2016"},{"key":"B291","doi-asserted-by":"publisher","first-page":"243","DOI":"10.14283\/jpad.2016.112","article-title":"PRECISION MEDICINE - the golden gate for detection, treatment and prevention of Alzheimer's Disease","volume":"3","author":"Hampel","year":"2016","journal-title":"J Prev Alzheimer's Dis"},{"key":"B292","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.phrs.2018.02.014","article-title":"Precision pharmacology for Alzheimer's disease","volume":"130","author":"Hampel","year":"2018","journal-title":"Pharmacol Res."},{"key":"B293","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.nbt.2012.03.004","article-title":"A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory","volume":"29","author":"Hood","year":"2012","journal-title":"N Biotechnol"},{"key":"B294","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12779\/dnd.2019.18.2.33","article-title":"A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation","volume":"18","author":"Kim","year":"2019","journal-title":"Dement Neurocognitive Disord"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00456\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T10:35:09Z","timestamp":1585650909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00456\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":294,"alternative-id":["10.3389\/fimmu.2020.00456"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00456","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"article-number":"456"}}